 |
Edelman represents Amgen as it moves to acquire Horizon Therapeutics for $27.8B, making it the biggest healthcare deal for the year.
Horizon produces medicines for rare autoimmune and severe inflammatory diseases. Tepezza, its top drug, treats thyroid eye disease, and helped boost Horizon’s revenues up 47 percent to $3.2B during the past year.
Robert Bradway, Amgen’s CEO, said the deal fits his company’s “strategy of delivering long-term growth by providing innovative medicines that address the needs of patients who suffer from serious diseases.”
He also noted that drugs in Horizon’s pipeline complement Amgen’s R&D portfolio.
Horizon disclosed last month that it was considering takeover offers from Johnson & Johnson and Sanofi.
Dublin-based Amgen trades on the NASDAQ.
Lex Suvanto, CEO of Edelman financial communications; Jamaal Mobley, executive VP; and Shannon Susko, Edelman Smithfield healthcare head, are working on the deal.
They are joined by Edelman Ireland CEO Joe Carmody, corporate head Piaras Kelly and Edelman Global Advisory managing director Feargal Purcell.
Longacre Square Partners represents Ancora Holdings as it urges the board of Big Yellow Group to conduct a strategic review of the UK’s No. 1 self-storage company.
Kekst CNC handles Getty Images as it begins a prepackaged Chapter 11 reorganization and receives a commitment from Koch Equity Development and the Getty family to invest $533M in the visual content company.
As capital concentrates among established firms, emerging managers must find new ways to earn investor confidence.
Teneo handles True Food Kitchen as the Scottsdale, AZ-based wellness food restaurant chain that counts Oprah Winfrey as a minority investor files for Chapter 11.
FGS Global and Teneo represent Canada’s billionaire Weston family as its Wittington Investments holding company acquires Boots Group, the 177-year-old UK health & beauty retailer, from Sycamore Partners for $8.9B.
